The novel treatment of the medication represents a major breakthrough in the care of type 2 diabetes. Distinct from existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide366893.blog2news.com/42536372/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment